Santen Announces Completion of Share Buyback
Santen Pharmaceutical Co., Ltd. announced the completion of its share buyback program initially disclosed on May 13, 20251711.
The company repurchased a total of 19,800,000 shares, representing approximately 5.87% of its issued shares1711.
The aggregate purchase amount reached ¥31,896.01 million1711.
Latest tranche:
Between October 1, 2025 and November 5, 2025, Santen repurchased 3,224,600 shares for ¥4,998.66 million as part of the completed program1.
The buyback was conducted to enhance capital efficiency and maximize shareholder returns13.
The buyback was executed under a broader initiative approved by the Board of Directors, with a maximum budget of ¥35 billion3.
Following completion, Santen has also announced cancellation of a matching amount of treasury shares12.
Sources:
1. https://www.marketscreener.com/news/tranche-update-on-santen-pharmaceutical-co-ltd-s-equity-buyback-plan-announced-on-may-13-2025-ce7d5cd2dc81f62c
3. https://www.tipranks.com/news/company-announcements/santen-pharmaceutical-updates-on-share-buyback-progress-4
7. https://in.marketscreener.com/news/santen-pharmaceutical-co-ltd-s-equity-buyback-announced-on-may-13-2025-has-closed-with-19-800-0-ce7d5cd2dc81f222